Life Sciences

AbbVie-Durham-Rendering

DURHAM, N.C. — Biopharmaceutical company AbbVie (NYSE: ABBV) has announced plans for a new pharmaceutical manufacturing campus located in Durham, according to North Carolina Gov. Josh Stein.  AbbVie will invest $1.4 billion in the project over four years, marking the company’s largest capital commitment for a single campus to date and its first investment in the Tarheel State. Last year, AbbVie unveiled plans for a $195 million expansion its manufacturing plan in its hometown of North Chicago. Both projects are part of AbbVie’s $100 billion commitment to grow its U.S. research-and-development and capital investments over the next decade. Upon completion, the Durham campus will total 185 acres and will include drug product manufacturing facilities, next-generation laboratories, a warehouse, administrative offices and employee wellness facilities. AbbVie plans to produce small volume parenteral (i.e. prefilled syringes and vials for injection or infusion) drug products at the facility. Construction of the Durham campus is scheduled to begin this year and be completed by the end of 2028. AbbVie expects the construction process to support 2,000 temporary jobs. Several state and local entities, including The North Carolina Department of Commerce and the Economic Development Partnership of North Carolina, have collaborated with AbbVie on the project. AbbVie …

FacebookTwitterLinkedinEmail

PHILADELPHIA — Brandywine Realty Trust has received $87.3 million in C-PACE financing for 3151 Market Street, a 494,530-square-foot life sciences facility located within the developer’s Schuylkill Yards mixed-use destination in Philadelphia. The newly completed facility also includes traditional office space in addition to lab facilities and various tenant amenities. Nuveen Green Capital provided the financing, and the deal team says that the amount represents the largest C-PACE loan closing in Pennsylvania’s history. The Philadelphia Energy Authority will administer the financing.

FacebookTwitterLinkedinEmail

DACULA, GA. — Global biopharmaceutical company UCB has unveiled plans to invest $2 billion to establish its first U.S. pharmaceutical biologics manufacturing campus in Dacula, a city within metro Atlanta’s Gwinnett County. The new facility is expected to create 330 new jobs over the next several years at Rowen, a mixed-use innovation district focused on global health, agriculture and environmental sustainability. The 2,000-acre “knowledge community” is planned along Ga. Highway 316. The new 460,000-square-foot facility will anchor 79 acres that UCB purchased off Rowen Parkway. Brussels, Belgium-based UCB maintains an existing presence in Georgia. The company’s North American headquarters is located in Smyrna and currently supports more than 400 jobs spanning expertise in neurology and immunology. UCB is focused on developing innovative medicines for people living with severe neurological and autoimmune conditions such as epilepsy. UCB’s new manufacturing footprint marks the first major private investment at Rowen and the largest capital investment in Gwinnett County’s history. UCB says it will leverage advanced manufacturing technologies, including artificial intelligence, robotics and automation, while prioritizing efficient use of natural resources. Jean-Christophe Tellier, CEO of UCB, says the project is expected to generate approximately $5 billion in total economic impact, including more than 1,000 …

FacebookTwitterLinkedinEmail

BEVERLY, MASS. — American Surgical Co. has signed a 20,325-square-foot life sciences lease in Beverly, a northeastern suburb of Boston. The provider of medical tools is relocating from Shetland Park in nearby Salem to 100 Cummings Center, a newly built, 1.3 million-square-foot research-and-development facility. Joe Doyle and John Coakley of Cresa represented the tenant in the lease negotiations. Al Diamond represented the landlord, Cummings Properties, on an internal basis.

FacebookTwitterLinkedinEmail

PLANO, TEXAS — Riken Vitamin Co. has signed a 12,653-square-foot lease in Plano. The Japanese producer of food additives and vitamins is relocating from California to R&D at Legacy, a 374,275-square-foot flex development. Doug Carignan and Landon Brune of CBRE represented the tenant in the lease negotiations. Chase Lopez, James Mantzuranis and Sam Bass of Stream Realty Partners represented the landlord, BH Properties.

FacebookTwitterLinkedinEmail

LEXINGTON, MASS. — Nortiva Bio has signed a 22,881-square-foot life sciences lease renewal in Lexington, located northwest of Boston. The biopharmaceutical company’s space is located on the third floor of 20 Maguire Road, a 101,310-square-foot converted building. Alex Plaisted and Don Domoretsky of CBRE represented the landlord, a partnership between Investcorp and Griffith Properties, in the lease negotiations.

FacebookTwitterLinkedinEmail

LEXINGTON, MASS. — Convatec has signed a life sciences lease expansion and extension in Lexington, located northwest of Boston. The medical products and technology company now occupies 24,572 square feet on the second floor of 20 Maguire Road, a 101,310-square-foot converted building. Alex Plaisted and Don Domoretsky of CBRE represented the landlord, a partnership between Investcorp and Griffith Properties, in the lease negotiations.

FacebookTwitterLinkedinEmail

MORRISVILLE, N.C. — Foxfield has purchased 3503 Page Road, a newly built, 57,000-square-foot life sciences building located in Morrisville, about 14 miles west of Raleigh. The seller and sales price were not disclosed. Kryosphere, a biorepository solutions and cold chain logistics user, operates the facility under a 12-year net lease. The company has invested $5 million into the specialized build-out for pharmaceutical-grade cold storage infrastructure, with plans for an additional $5 million investment for equipment upgrades, according to Foxfield. Built in 2025, 3503 Page Road is situated within the World Trade Park industrial park and offers direct connectivity to I-40, I-540 and Raleigh-Durham International Airport. The building features industrial space, lab support and research-and-development space, as well as 24-foot clear heights.

FacebookTwitterLinkedinEmail

KANKAKEE, ILL. — CSL, a global pharmaceutical manufacturer based in Melbourne, Australia, has broken ground on a $1.5 billion expansion of its campus in Kankakee, roughly 60 miles southwest of Chicago. The company has operated at the site since purchasing the former Armour Pharmaceutical Co. plant in 2004, according to multiple media outlets. CSL is developing a new 330,000-square-foot facility at the site that will generate 300 permanent jobs and 800 construction jobs, in addition to the 1,200 existing positions at the plant. The new investment builds on the $3 billion that CSL has invested in the United States since 2018, which has created more than 6,500 American jobs. “Illinois is leading the way in life sciences manufacturing, and CSL’s $1.5 billion investment is a powerful vote of confidence in our state,” said Illinois Gov. JB Pritzker in a statement. “CSL’s continued growth in Kankakee County builds on decades of innovation and manufacturing leadership right here in Illinois. We’re proud to partner with CSL as they expand their footprint and deepen their commitment to communities across our state.” The Kankakee campus is expected to supply 100 percent of the U.S. demand for immunoglobulin therapies (i.e., plasma-derived antibodies treatments), according to CSL. …

FacebookTwitterLinkedinEmail

TOPEKA, KAN. — Link Innovation Labs, a 17,000-square-foot hub designed to support startups, researchers, small businesses and industry partners, has opened in Topeka’s Innovation District. Link Innovation Labs offers office space, coworking areas, conference rooms, a dedicated pitch and event space and a flexible lab facility designed for early-stage animal health and bioscience companies. The space includes BSL-1 and BSL-2 laboratories, addressing a growing need for entry-level wet lab capacity for startups advancing alternative proteins, pet therapeutics, herd health technologies and AI-enabled biosecurity solutions. Link Innovation Labs is part of GO Topeka’s broader strategy to strengthen the region’s entrepreneurial ecosystem, support business formation and expansion and create high-quality jobs throughout Topeka and Shawnee County.

FacebookTwitterLinkedinEmail
Newer Posts